Sangani Hospitals Limited (NSE:SANGANI)
India · Delayed Price · Currency is INR 53.90
-0.60 (-1.10%)
Sep 11, 2026, 2:31 PM IST
Sangani Hospitals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,070 | 211.85 | 156.76 | 156.68 | 102.83 |
Other Revenue | 5.97 | - | - | - | 0.12 |
| 1,076 | 211.85 | 156.76 | 156.68 | 102.95 | |
Revenue Growth | 407.69% | 35.14% | 0.05% | 52.19% | 106.64% |
Cost of Revenue | 812.09 | 141.26 | 103.87 | 94.42 | 44.94 |
Gross Profit | 263.46 | 70.59 | 52.89 | 62.26 | 58.01 |
Selling, General & Admin | - | 6.6 | 0.04 | 0.16 | 1.19 |
Other Operating Expenses | 176.63 | 38.94 | 21.37 | 31.19 | 26.09 |
Operating Expenses | 186.5 | 51.5 | 24.26 | 42.04 | 28.14 |
Operating Income | 76.96 | 19.09 | 28.63 | 20.22 | 29.87 |
Interest Expense | - | - | -0.32 | - | -0.43 |
Interest & Investment Income | - | 13.46 | 8.01 | 0.88 | 0.01 |
Other Non Operating Income (Expenses) | -0.29 | 2.07 | 0.01 | - | - |
EBT Excluding Unusual Items | 76.67 | 34.62 | 36.33 | 21.1 | 29.45 |
Gain (Loss) on Sale of Assets | - | - | - | -0.63 | - |
Other Unusual Items | -20.14 | - | - | - | - |
Pretax Income | 56.54 | 34.62 | 36.33 | 20.47 | 29.45 |
Income Tax Expense | 21.42 | 8.68 | 9.36 | 5.15 | 7.51 |
Earnings From Continuing Operations | 35.12 | 25.94 | 26.97 | 15.32 | 21.94 |
Minority Interest in Earnings | -5.22 | -0.01 | - | - | - |
Net Income | 29.9 | 25.93 | 26.97 | 15.32 | 21.94 |
Preferred Dividends & Other Adjustments | - | - | - | - | 11.41 |
Net Income to Common | 29.9 | 25.93 | 26.97 | 15.32 | 10.54 |
Net Income Growth | 15.31% | -3.86% | 76.04% | 45.41% | 33.42% |
Shares Outstanding (Basic) | 14 | 14 | 12 | 9 | 4 |
Shares Outstanding (Diluted) | 14 | 14 | 12 | 9 | 4 |
Shares Change | - | 11.02% | 31.24% | 139.50% | 133.86% |
EPS (Basic) | 2.17 | 1.88 | 2.17 | 1.62 | 2.67 |
EPS (Diluted) | 2.17 | 1.88 | 2.17 | 1.62 | 2.67 |
EPS Growth | 15.31% | -13.40% | 34.14% | -39.28% | -42.95% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -0.35 | 12.54 | 22.81 | -94.48 | 4.87 |
Free Cash Flow Per Share | -0.03 | 0.91 | 1.84 | -9.99 | 1.23 |
Gross Margin | 24.50% | 33.32% | 33.74% | 39.74% | 56.35% |
Operating Margin | 7.16% | 9.01% | 18.26% | 12.91% | 29.01% |
Profit Margin | 2.78% | 12.24% | 17.20% | 9.78% | 10.23% |
Free Cash Flow Margin | -0.03% | 5.92% | 14.55% | -60.30% | 4.73% |
EBITDA | 86.83 | 25.05 | 31.48 | 30.33 | 30.73 |
EBITDA Margin | 8.07% | 11.82% | 20.08% | 19.36% | 29.85% |
D&A For EBITDA | 9.87 | 5.96 | 2.85 | 10.11 | 0.86 |
EBIT | 76.96 | 19.09 | 28.63 | 20.22 | 29.87 |
EBIT Margin | 7.16% | 9.01% | 18.26% | 12.91% | 29.01% |
Effective Tax Rate | 37.89% | 25.07% | 25.77% | 25.15% | 25.50% |
Revenue as Reported | 1,076 | 227.92 | 165.2 | 157.62 | 102.97 |
Advertising Expenses | - | 1.59 | 0.04 | 0.16 | 0.91 |